Article Text

Download PDFPDF
Review: postmenopausal hormone therapy increases risk of stroke and venous thromboembolism but not coronary heart disease events

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

P M Bath

Dr P M Bath, University of Nottingham, Nottingham, UK;


What are the effects of hormone therapy (HT) on arterial and venous vascular events in postmenopausal women?


Included studies compared risk of vascular events in postmenopausal women receiving HT with that of women receiving placebo or no HT. Outcomes were cerebrovascular disease events (stroke or transient ischaemic attack), coronary heart disease (CHD) events (myocardial infarction, sudden cardiac death, or unstable angina), and venous thromboembolic (VTE) disease events (deep venous thrombosis, pulmonary embolism, or cerebral sinus thrombosis).


Cochrane Library, Medline, PubMed, and EMBASE/Excerpta Medica (to Jan 2008); and reference lists were searched for randomised controlled trials (RCTs) published in English. 31 trials (n = 44 113, mean age 47–75 y) met the selection criteria. Duration of …

View Full Text


  • Source of funding: no external funding.